The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ICICI Prudential Mutual Fund has informed the stock exchanges that it sold 33,44,886 equity shares (2.03% of paid-up capital) of Gland Pharma Ltd through the secondary market between April 12, 2025 and August 06, 2025. As a result, its holding in the company declined from 83,71,114 shares (5.08%) to 50,26,228 shares (3.05%). The fund clarified that the shares are held purely from an investment perspective and not with any intention to seek control. The total equity share capital of Gland Pharma stands at 16,47,56,423 shares of face value Re. 1 each.
This is a notable reduction by a large institutional investor, which could exert mild short-term selling pressure on the stock. However, the holding remains meaningful at 3.05%, suggesting the fund has not completely exited the stock.